Do you want to read an article? Please log in or register.
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry
Macular DiseasesRetinal Diseases
Related content
Macular Diseases
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry
Graefes Arch Clin Exp Ophthalmol
Figueras-Roca M, Parrado-Carrillo A, Nguyen V, Casaroli-Marano RP, Moll-Udina A, Gillies MC, Barthelmes D, Zarranz-Ventura J
doi: 10.1007/s00417-020-05016-9
Macular Diseases
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Adv Ther.
Carrasco J, Pietsch GA, Nicolas MP, Koerber C, Bennison C, Yoon J
doi: 10.1007/s12325-019-01147-6.
Macular Diseases
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry
Ophthalmology.
Rao P, Lum F, Wood K, Salman C, Burugapalli B, Hall R, Singh S, Parke DW 2nd2, Williams GA
doi: 10.1016/j.ophtha.2017.10.010.
Macular Diseases
Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry
Ophthalmology.
Bhandari S, Nguyen V, Arnold J, Young S, Banerjee G, Gillies M, Barthelmes D
doi: 10.1016/j.ophtha.2019.10.006.
Macular Diseases
ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Retina.
Nguyen V, Leung KFC, Nguyen CL, Squirrell D, Essex R, Arnold J, Young S, Barthelmes D, Gillies M; Fight Retinal Blindness! Study Group.
doi: 10.1097/IAE.0000000000002485.
RECOMMENDED
Macular Diseases
FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fight Retinal Blindness! Project
★ 2
Recommended by
PD Dr Moreno Menghini, Faculty Member
doi: 10.1097/IAE.0000000000002798.
Macular Diseases
Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project
Br J Ophthalmol.
Daien V, Nguyen V, Essex RW, Guymer R, Arnold JJ, Munk M, Ceklic L, Gillies MC, Barthelmes D, Fight Retinal Blindness! investigators.
doi: 10.1136/bjophthalmol-2019-315055.
RECOMMENDED
Macular Diseases
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
★ 2
Recommended by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Br J Ophthalmol
Daien V, Finger RP, Talks JS, Mitchell P, Wong TY, Sakamoto T, Eldem BM, Korobelnik JF
doi: 10.1136/bjophthalmol-2020-317434
Macular DiseasesRetinal Diseases
Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group
Ophthalmology.
Writing Committee for the OPTOS PEripheral RetinA (OPERA) study (Ancillary Study of Age-Related Eye Disease Study 2), Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA, Toth CA, Friberg TR, Chew EY
doi: 10.1016/j.ophtha.2016.12.004.